版本:
中国

BRIEF-Clovis oncology says entered into a manufacturing services agreement - sec filing

Oct 4 Clovis Oncology Inc

* Says Clovis Oncology and Lonza Ltd entered into a manufacturing services agreement - SEC filing

* Deal provides Lonza will be non-exclusive manufacturer of Rucaparib Api during term of deal , which expires on December 31, 2025 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐